2017

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis
Thoennissen G, Görlich D, Bacher U, Aufenberg T, Hüsken A, Hansmeier A, Evers G, Mikesch J, Fritz F, Bokemeyer C, Müller-Tidow C, Stelljes M, Mesters R, Krug U, Kropff M, Thoennissen N, Berdel W
ACTA HAEMATOL-BASEL. 2017;137(3):163-172.

2015

Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT
Karagiannis P, Guth N, Thoennissen G, Bern C, Sperveslage J, Oschlies I, Bokemeyer C, Klapper W, Wardelmann E, Thoennissen N
Clin Sarcoma Res. 2015;5:24.

2014

Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance
Bettenworth D, Nowacki T, Ross M, Kyme P, Schwammbach D, Kerstiens L, Thoennissen G, Bokemeyer C, Hengst K, Berdel W, Heidemann J, Thoennissen N
MOL NUTR FOOD RES. 2014;58(7):1474-1490.

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis
Stelljes M, Krug U, Beelen D, Braess J, Sauerland M, Heinecke A, Ligges S, Sauer T, Tschanter P, Thoennissen G, Berning B, Kolb H, Reichle A, Holler E, Schwerdtfeger R, Arnold R, Scheid C, Müller-Tidow C, Woermann B, Hiddemann W, Berdel W, Büchner T
J CLIN ONCOL. 2014;32(4):288-96.

2013

The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer
Aribi A, Gery S, Lee D, Thoennissen N, Thoennissen G, Alvarez R, Ho Q, Lee K, Doan N, Chan K, Toh M, Said J, Koeffler H
INT J CANCER. 2013;132(12):2730-7.

DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center
Mikesch J, Kuhlmann M, Demant A, Krug U, Thoennissen G, Schmidt E, Kessler T, Schliemann C, Pohlen M, Mohr M, Evers G, Köhler G, Wessling J, Mesters R, Müller-Tidow C, Berdel W, Thoennissen N
ANN HEMATOL. 2013;92(8):1041-8.

BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Ng C, Titz B, Hurtz C, Sadiyah M, Nowak D, Thoennissen G, Rand V, Graeber T, Koeffler H, Carroll W, Willman C, Hall A, Igarashi K, Melnick A, Müschen M
NAT MED. 2013;19(8):1014-22.

2012

C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice
Kyme P, Thoennissen N, Tseng C, Thoennissen G, Wolf A, Shimada K, Krug U, Lee K, Müller-Tidow C, Berdel W, Hardy W, Gombart A, Koeffler H, Liu G
J CLIN INVEST. 2012;122(9):3316-29.

POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience
Thoennissen G, Thoennissen N, Fritz F, Hilbig A, Kerkhoff A, Liersch R, Krug U, Koschmieder S, Müller-Tidow C, Mesters R, Kropff M, Berdel W
ANN HEMATOL. 2012;91(9):1419-25.

Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma
Thoennissen N, Thoennissen G, Abbassi S, Nabavi-Nouis S, Sauer T, Doan N, Gery S, Müller-Tidow C, Said J, Koeffler H
LEUKEMIA LYMPHOMA. 2012;53(8):1577-85.

2011

Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN
Thoennissen N, Lasho T, Thoennissen G, Ogawa S, Tefferi A, Koeffler H
AM J HEMATOL. 2011;86(8):703-5.

1994

Altered left ventricular diastolic function post-atrial pacing in coronary artery disease and left ventricular hypertrophy: further insights by pulmonary venous flow analysis
Hoffmann R, Lambertz H, Thoennissen G, Flachskampf F, Hanrath P
EUR HEART J. 1994;15(8):1096-105.

Letzte Aktualisierung aus dem FIS: 25.04.2024 - 00:41 Uhr